Prediction of TFR eligibility in the total CP-CML cohort of 366 patients. (A) Cumulative incidence of TFR eligibility based on halving time quartiles. (B) Cumulative incidence of TFR eligibility based on the BCR-ABL1 fold-reduction. (C) Cumulative incidence of TFR eligibility based on the 3-month BCR-ABL1 value.